SHUKRA MEDTECH LIMITED (NSE:SHUKRAPHAR)

Market Cap	36.10B +101.2%
Revenue (ttm)	1.11B +206.6%
Net Income	443.21M +270.6%
EPS	0.99 +419.8%
Shares Out	n/a
PE Ratio	83.21
Forward PE	n/a
Dividend	0.01 (0.01%)
Ex-Dividend Date	Sep 21, 2026

Volume	5,281,583
Open	81.90
Previous Close	81.58
Day's Range	81.06 - 84.50
52-Week Range	40.06 - 84.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 3, 2026

About SHUKRA MEDTECH LIMITED

SHUKRA MEDTECH LIMITED engages in the manufacturing, marketing, and export of pharmaceutical formulations in India and internationally. The company offers various products, such as antibiotics, anti biotics, macrolides, quinolones, anti bacterial, anti fungal, anti malarial, anti viral, anti protozoal, anti anthelmintic, sedative and tranquilliser, anti depressant, anti manic, anti emetic, anti ulcer, beta blockers, diuretics, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycem...

• Industry: Pharmaceutical Preparations
• Founded: 1993
• Employees: 115
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SHUKRAPHAR

Financial Performance

In fiscal year 2026, SHUKRA MEDTECH LIMITED's revenue was 567.27 million, an increase of 73.31% compared to the previous year's 327.32 million. Earnings were 220.58 million, an increase of 130.37%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 11, 2026

Data Sources Report a data error